Surge in unapproved GLP-1 drugs alarming poison control, safe medicine advocates
5 Articles
5 Articles
Semaglutide and Tirzepatide are profoundly changing the treatment of type 2 diabetes and obesity. But their therapeutic success is creating a misunderstanding: to consider them simply as slimming drugs. Actually, when prescribed to a patient with diabetes or clinically significant obesity, we are faced with pharmacological therapies for chronic diseases, with [...] The article Boom buying slimming drugs, the alarm of experts: "I'm not an aesthet…
GLP-1 analogue drugs, such as semaglutide and liraglutide, have changed the treatment of obesity. The risk arises when they are bought without prescription or provenance, and applied without diagnosis.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium







